RVX
$0.04
-11.111%
Resverlogix Corp.Insider Activity
Last updated: May 1, 2025, 8:53 PM ET
Profile
Company Description
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Insider Activity
Financial Data provided by QuoteMedia captures transactions reported on SEDI. To view this company’s financial statements, please visit the Financials & Filings.
Time Range
3 Months
Buys
3
months2 Buys
# of Shares
Sells
3
months1 Sells
# of Shares